Filed: 5/15/2023ACC: 0000919574-23-003259
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $39.59M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$39.59M
Total AUM (reported)
17.09M
Total Shares
Allocation by class
COM$25.60M64.7%
TR UNIT$6.53M16.5%
COM NEW$2.69M6.8%
S&P OILGAS EXP$2.23M5.6%
ORD SHS$1.35M3.4%
ALERIAN MLP$1.14M2.9%
*W EXP 11/22/202$40.5K0.1%
Portfolio Concentration
Top 3$29.82M75.3%
4–10$9.25M23.4%
11–25$517.4K1.3%
Top 3 weight
75.3%
Top 10 weight
98.7%
Voting Authority Distribution
Total shares with voting rights: 17.09M
Sole
Full voting authority
17.09M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
SAVARA INC
SOLEShares6.90M
TypeSH
Market value$13.45M
33.97%
Sole
6.90M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares6.04M
TypeSH
Market value$9.84M
24.86%
Sole
6.04M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares15.95K
TypeSH
Market value$6.53M
16.49%
Sole
15.95K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.40M
TypeSH
Market value$2.69M
6.80%
Sole
1.40M
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares17.50K
TypeSH
Market value$2.23M
5.64%
Sole
17.50K
Shared
0.00
None
0.00
VECTIVBIO HLDG AG
SOLEShares156.65K
TypeSH
Market value$1.35M
3.40%
Sole
156.65K
Shared
0.00
None
0.00
ALPS ETF TR
SOLEShares29.50K
TypeSH
Market value$1.14M
2.88%
Sole
29.50K
Shared
0.00
None
0.00
MOLECULAR TEMPLATES INC
SOLEShares2.05M
TypeSH
Market value$779.9K
1.97%
Sole
2.05M
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares211.74K
TypeSH
Market value$675.5K
1.71%
Sole
211.74K
Shared
0.00
None
0.00
ALLAKOS INC
SOLEShares86.53K
TypeSH
Market value$385.1K
0.97%
Sole
86.53K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares40.58K
TypeSH
Market value$335.6K
0.85%
Sole
40.58K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares68.32K
TypeSH
Market value$129.8K
0.33%
Sole
68.32K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares21.33K
TypeSH
Market value$40.5K
0.10%
Sole
21.33K
Shared
0.00
None
0.00
BRIDGETOWN HOLDINGS LTD
SOLEShares39.77K
TypeSH
Market value$7.0K
0.02%
Sole
39.77K
Shared
0.00
None
0.00
LANVIN GROUP HOLDINGS LIMITE
SOLEShares12K
TypeSH
Market value$4.5K
0.01%
Sole
12K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SAVARA INCSOLE | COM | 6.90M | SH | $13.45M 33.97% | 6.90M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 6.04M | SH | $9.84M 24.86% | 6.04M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 15.95K | SH | $6.53M 16.49% | 15.95K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.40M | SH | $2.69M 6.80% | 1.40M | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P OILGAS EXP | 17.50K | SH | $2.23M 5.64% | 17.50K | 0.00 | 0.00 |
VECTIVBIO HLDG AGSOLE | ORD SHS | 156.65K | SH | $1.35M 3.40% | 156.65K | 0.00 | 0.00 |
ALPS ETF TRSOLE | ALERIAN MLP | 29.50K | SH | $1.14M 2.88% | 29.50K | 0.00 | 0.00 |
MOLECULAR TEMPLATES INCSOLE | COM | 2.05M | SH | $779.9K 1.97% | 2.05M | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 211.74K | SH | $675.5K 1.71% | 211.74K | 0.00 | 0.00 |
ALLAKOS INCSOLE | COM | 86.53K | SH | $385.1K 0.97% | 86.53K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 40.58K | SH | $335.6K 0.85% | 40.58K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 68.32K | SH | $129.8K 0.33% | 68.32K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | *W EXP 11/22/202 | 21.33K | SH | $40.5K 0.10% | 21.33K | 0.00 | 0.00 |
BRIDGETOWN HOLDINGS LTDSOLE | *W EXP 09/30/202 | 39.77K | SH | $7.0K 0.02% | 39.77K | 0.00 | 0.00 |
LANVIN GROUP HOLDINGS LIMITESOLE | *W EXP 01/14/202 | 12K | SH | $4.5K 0.01% | 12K | 0.00 | 0.00 |